Discover the causes behind fatty liver disease, a condition affecting 25% of adults worldwide, and learn simple lifestyle ...
Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH) is a disease that occurs when steatosis (a buildup of fat) in the liver causes liver inflammation and damage.
Scientists have identified the Plvap gene as a key regulator of metabolism during fasting. Disabling it in mice prevented the ...
THR-beta agonists are the only medication approved to treat metabolic dysfunction–associated steatohepatitis (MASH), a severe ...
Sagimet Biosciences Inc. (Nasdaq: SGMT), clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today reported financial ...
TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitorFirst-in-human Phase 1 trial initiation planned in 2025SAN MATEO, Calif., ...
Discover the 5 ways alcohol progressively harms your liver, from early warning signs to serious complications, plus expert ...
Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...
NAD+ boosters can affect how certain medications like insulin, blood pressure lowering, antidepressants, and cancer ...
Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral ...
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results